Loading provider…
Loading provider…
General Practice Physician in Mountain View, CA
NPI: 1033551783HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1997 - 2027
MI State Medical License
1986 - 2026
NY State Medical License
1979 - 2026
PA State Medical License
1992 - 2004

American Board of Internal Medicine
Internal Medicine
Albany Medical Center
Residency • Internal Medicine
1978 - 1981
New York University School of Medicine
Medical School
Until 1978
Authors: Krause, Kevin M, Barriere, Steven L, Kitt, Michael M, Benton, Bret M
Journal: Diagn Microbiol Infect Dis
The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study.
Authors: Charles Gibson
Publication Date: 2013-08-06
Gefapixant in two randomised dose-escalation studies in chronic cough.
Authors: Steven Smith, Peter Butera, Mandel Sher
Publication Date: 2020-03-20
Lead Sponsor: Attenua, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Bradanicline
Lead Sponsor: Vyne Therapeutics Inc.
Intervention / Treatment: DRUG: Matching Placebo Tablets, DRUG: 5 mg Serlopitant Tablets
Lead Sponsor: Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Intervention / Treatment: DRUG: Placebo, DRUG: Gefapixant 100 mg